We are live on ! Find out more
AA

AlphaMark Advisors Portfolio holdings

AUM $231M
1-Year Est. Return 19.98%
This Fund
S&P 500
This Quarter Est. Return
+11.57%
1 Year Est. Return
+19.98%
3 Year Est. Return
+26.38%
5 Year Est. Return
+72.27%
10 Year Est. Return
+180.76%
AUM
$263M
AUM Growth
+$30M
Cap. Flow
+$4.97M
Cap. Flow %
1.89%
Top 10 Hldgs %
40.23%
Holding
838
New
89
Increased
148
Reduced
180
Closed
100

Similar funds

AlphaMark Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, AlphaMark Advisors held 838 positions worth $263M, up 13% from $233M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

AlphaMark Advisors's Q4 2023 filing shows 89 new, 148 increased, 180 reduced and 100 closed positions. Its largest new stake was AMR CORP: 997 shares worth $338K. The largest sale was Edwards Lifesciences, an estimated $1.48M.

By sector, the portfolio is most concentrated in Financials at 8.1% of assets, up from 6.5% a quarter earlier, followed by Technology and Consumer Staples.

  • AlphaMark Advisors's largest Q4 2023 buy was AMR CORP: 997 shares worth $338K.
  • AlphaMark Advisors added most to First Trust Smith Opportunistic Fixed Income ETF in Q4 2023, an estimated $2.24M increase.
  • AlphaMark Advisors's biggest Q4 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.19M.
  • AlphaMark Advisors fully exited Edwards Lifesciences in Q4 2023, selling an estimated $1.48M.
  • AlphaMark Advisors's ten largest holdings make up 40% of its $263M portfolio in Q4 2023.
  • AlphaMark Advisors opened 89 new positions and closed 100 in Q4 2023.
  • AlphaMark Advisors's portfolio value rose 13% quarter-over-quarter to $263M.

Based on AlphaMark Advisors's 13F filing for Q4 2023, filed 19 Jan 2024.